SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-16-731651
Filing Date
2016-10-05
Accepted
2016-10-05 17:25:17
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d274304ds1.htm S-1 1631677
2 EX-4.2 d274304dex42.htm EX-4.2 20919
3 EX-21.1 d274304dex211.htm EX-21.1 2839
4 EX-23.2 d274304dex232.htm EX-23.2 1758
5 EX-99.1 d274304dex991.htm EX-99.1 29576
6 EX-99.2 d274304dex992.htm EX-99.2 10410
7 EX-99.3 d274304dex993.htm EX-99.3 13471
8 EX-99.4 d274304dex994.htm EX-99.4 10412
9 EX-99.5 d274304dex995.htm EX-99.5 13214
10 EX-99.6 d274304dex996.htm EX-99.6 18405
11 EX-99.7 d274304dex997.htm EX-99.7 19062
12 EX-99.8 d274304dex998.htm EX-99.8 5482
13 GRAPHIC g274304g12m94.jpg GRAPHIC 41100
  Complete submission text file 0001193125-16-731651.txt   1835206
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-213986 | Film No.: 161923366
SIC: 2834 Pharmaceutical Preparations